Harvard Bioscience (HBIO) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $7.55 +6.64%
Financial Fact:
Restructuring charges: -17K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Restructuring charges: -17K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $20.6 million versus the consensus estimate of $19 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
- BKV Corporation (BKV) files for 5.315M share offering by selling stockholders
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
